Here is a breakdown of major shareholders in CVS Health Corporation (NYSE: CVS)

2,310 institutions hold shares in CVS Health Corporation (CVS), with 2.22M shares held by insiders accounting for 0.17% while institutional investors hold 78.14% of the company’s shares. The shares outstanding are 1.31B, and float is at 1.31B with Short Float at 1.19%. Institutions hold 78.00% of the Float.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 105.38 million shares valued at $7.2 billion. The investor’s holdings represent 8.04% of the CVS Shares outstanding. As of Dec 30, 2020, the second largest holder is Blackrock Inc. with 92.48 million shares valued at $6.32 billion to account for 7.05% of the shares outstanding. The other top investors are State Street Corporation which holds 54.46 million shares representing 4.15% and valued at over $3.72 billion, while Capital World Investors holds 2.64% of the shares totaling 34.66 million with a market value of $2.37 billion.

CVS Health Corporation (NYSE: CVS) is 3.07% higher on its value in year-to-date trading and has touched a low of $52.04 and a high of $77.23 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CVS stock was last observed hovering at around $69.64 in the last trading session, with the day’s gains setting it 0.76% off its average median price target of $86.00 for the next 12 months. It is also 30.98% off the consensus price target high of $102.00 offered by 27 analysts, but current levels are 2.22% higher than the price target low of $72.00 for the same period.

Currently trading at $70.40, the stock is -2.63% and -2.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.82 million and changing 1.09% at the moment leaves the stock 7.47% off its SMA200. CVS registered 9.44% gain for a year compared to 6-month gain of 10.22%. The firm has a 50-day simple moving average (SMA 50) of $73.27 and a 200-day simple moving average (SMA200) of $66.02.

The stock witnessed a -3.84% loss in the last 1 month and extending the period to 3 months gives it a 6.04%, and is -3.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.87% over the week and 2.31% over the month.

CVS Health Corporation (CVS) has around 300000 employees, a market worth around $93.76B and $268.71B in sales. Current P/E ratio is 12.87 and Fwd P/E is 8.68. Profit margin for the company is 2.70%. Distance from 52-week low is 35.28% and -8.84% from its 52-week high. The company has generated returns on investments over the last 12 months (7.40%).

CVS Health Corporation (CVS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for CVS Health Corporation (CVS) is a “Overweight”. 27 analysts offering their recommendations for the stock have an average rating of 2.00, where 6 rate it as a Hold and 3 think it is a “Overweight”. 18 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

CVS Health Corporation is expected to release its quarterly report on 05/04/2021 and quarterly earnings per share for the current quarter are estimated at $1.73 with sales reaching $68.34B over the same period.The EPS is expected to grow by 7.60% this year, but quarterly earnings will post 4.20% year-over-year. Quarterly sales are estimated to grow 2.40% in year-over-year returns.

CVS Health Corporation (CVS) Insider Activity

A total of 23 insider transactions have happened at CVS Health Corporation (CVS) in the last six months, with sales accounting for 8 and purchases happening 15 times. The most recent transaction is an insider purchase by LUDWIG EDWARD J, the company’s Director. SEC filings show that LUDWIG EDWARD J bought 3,000 shares of the company’s common stock on Feb 17 at a price of $72.00 per share for a total of $0.22 million. Following the purchase, the insider now owns 14334.0 shares.

CVS Health Corporation disclosed in a document filed with the SEC on Jan 19 that MERLO LARRY J (President and CEO) sold a total of 62,893 shares of the company’s common stock. The trade occurred on Jan 19 and was made at $77.00 per share for $4.84 million. Following the transaction, the insider now directly holds 0.52 million shares of the CVS stock.

Still, SEC filings show that on Jan 12, Bisaccia Lisa (EVP and Chief HR Officer) disposed off 25,177 shares at an average price of $77.00 for $1.94 million. The insider now directly holds 46,588 shares of CVS Health Corporation (CVS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

CVS Health Corporation (CVS): Who are the competitors?

The company’s main competitors (and peers) include Walgreens Boots Alliance Inc. (WBA) that is trading 3.49% up over the past 12 months. Short interest in the company’s stock has fallen -9.78% from the last report on Dec 30, 2020 to stand at a total of 17.06 million short shares sold with a short interest ratio of 2.36.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free